While we demonstrate KohakuRAG with the WattBot 2025 dataset, the core library is completely domain-agnostic and can be applied to any document corpus.

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...